The clinical research study will now be administered by the FDA PAC team across three study sites, including the FDA Parklawn Building in Rockville Maryland, The Arkansas Children’s Hospital in Little Rock, Arkansas, and The Cleveland Clinic in Cleveland, Ohio.

The FDA PAC is comprised of a Principal Investigator, Co-Principal Investigator, Co-Investigators, and additional staff (see Research Team Menu for complete list of personnel affiliated with this project).